As of April 16, 2025, Omnicell (OMCL) has a market cap of $1.47 billion USD. According to our data, Omnicell is ranked No.4461 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $1.47 B |
-28.78%
|
Dec 31, 2024 | $2.06 B |
18.31%
|
Dec 29, 2023 | $1.74 B |
-25.37%
|
Dec 30, 2022 | $2.34 B |
-72.06%
|
Dec 31, 2021 | $8.36 B |
50.34%
|
Dec 31, 2020 | $5.56 B |
46.87%
|
Dec 31, 2019 | $3.79 B |
33.44%
|
Dec 31, 2018 | $2.84 B |
26.27%
|
Dec 29, 2017 | $2.25 B |
43.07%
|
Dec 30, 2016 | $1.57 B |
9.07%
|
Dec 31, 2015 | $1.44 B |
-6.16%
|
Dec 31, 2014 | $1.53 B |
29.73%
|
Dec 31, 2013 | $1.18 B |
71.69%
|
Dec 31, 2012 | $0.69 B |
-9.99%
|
Dec 30, 2011 | $0.77 B |
14.33%
|
Dec 31, 2010 | $0.67 B |
23.61%
|
Dec 31, 2009 | $0.54 B |
-4.26%
|
Dec 31, 2008 | $0.57 B |
-54.66%
|
Dec 31, 2007 | $1.25 B |
44.55%
|
Dec 29, 2006 | $0.86 B |
55.90%
|
Dec 30, 2005 | $0.55 B |
8.64%
|
Dec 31, 2004 | $0.51 B |
-32.10%
|
Dec 31, 2003 | $0.75 B |
511.32%
|
Dec 31, 2002 | $0.12 B |
-70.22%
|
Dec 31, 2001 | $0.41 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Baxter
BAX
|
$14.26 B |
0.000 M
|
![]() USA
|
![]() Becton Dickinson
BDX
|
$58.01 B |
-0.001 M
|
![]() USA
|
![]() McKesson
MCK
|
$86.83 B |
0.003 M
|
![]() USA
|
![]() Cardinal Health
CAH
|
$32.43 B |
-0.000 M
|
![]() USA
|
![]() Medtronic
MDT
|
$105.64 B |
0.002 M
|
![]() Ireland
|
![]() Stryker Corporation
SYK
|
$132.37 B |
-0.002 M
|
![]() USA
|
![]() General Electric
GE
|
$198.03 B |
-0.000 M
|
![]() USA
|
![]() Philips
PHG
|
$22.04 B |
-0.001 M
|
![]() Netherlands
|
![]() Intuitive Surgical
ISRG
|
$174.93 B |
-0.001 M
|
![]() USA
|
![]() Thermo Fisher Scientific
TMO
|
$166.47 B |
0.002 M
|
![]() USA
|
![]() Danaher
DHR
|
$135.88 B |
0.003 M
|
![]() USA
|
![]() Abbott Laboratories
ABT
|
$218.91 B |
-0.002 M
|
![]() USA
|
Market Cap | = | OMCL Stock Price | * | OMCL Shares Outstanding |
= | $31.35 | * | 46.84 M | |
= | $1.47 B |